Description
Retatrutide 20mg: The Triple Agonist Peptide for Advanced Metabolic Research
Unlock the potential of Retatrutide 20mg, a groundbreaking experimental peptide, designed to target multiple hormonal pathways for superior metabolic outcomes. As a synthetic analog mimicking GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors, Retatrutide represents the next evolution in peptide research, offering a multi-faceted approach to appetite regulation, energy expenditure, and fat metabolism. Ideal for investigative studies on obesity, type 2 diabetes, and related conditions, this high-purity formulation (99%+) is supplied in a convenient 20mg vial for precise dosing in laboratory settings.
Mechanism of Action
Retatrutide interacts with key receptors in the brain and gastrointestinal tract to emulate natural hormones, suppressing appetite, slowing gastric emptying, and enhancing calorie conversion into usable energy. This triple-receptor activation sets it apart from single- or dual-agonist peptides like semaglutide or tirzepatide, potentially amplifying effects on hunger control and metabolic efficiency.
Key Research Benefits
– Profound Weight Reduction: Clinical data shows up to 24% body weight loss over 48 weeks, outperforming existing GLP-1 therapies.
– Appetite and Craving Control: Promotes prolonged satiety, reducing caloric intake without compromising energy levels.
– Metabolic Optimization: Improves insulin sensitivity, blood sugar regulation, and lipid profiles, supporting cardiovascular and liver health.
– Enhanced Energy Utilization: Boosts fat breakdown and metabolic rate via glucagon pathway activation, ideal for studies on energy homeostasis.
Dosage Considerations for Research
In trial protocols, Retatrutide is typically reconstituted and administered subcutaneously once weekly, starting at low doses (e.g., 2.5mg) and titrating up to 10mg for full therapeutic exploration. Always follow strict lab guidelines for reconstitution, storage (refrigerate at 2-8°C), and handling to maintain stability.
**Important Disclaimer**: Retatrutide is strictly for research purposes only. Availability subject to ongoing clinical development, with potential market entry in late 2025.
Why 3L Peptides?
-
Independently lab-certified for purity
-
99.521% consistent peptide quality
-
Trusted by researchers worldwide
⚠️ For research purposes only.
Reconstitution: 2ml BAC water per 10mg vial → Calculate Here
Dose: 0.5mg, 3x per week (10 units) (subQ)
Cycle: 8 weeks on | Time Off: 8 weeks or until goal weight
Benefits: Triple-receptor activation, maximum fat loss, metabolic optimization
Notes: Retatrutide formulation, follow titration protocol.
- Always titrate GLP-1s slowly to avoid nausea
- Use peptidedeals.co/calculator for precise reconstitution
- Store reconstituted peptides refrigerated for up to 30 days
- Rotate injection sites to prevent lipodystrophy
- Get comprehensive blood work before and during cycles
- Bioregulators follow strict 30-day protocols, 2x yearly maximum
🔬 Legal Disclaimer: For research and educational purposes only. These compounds are not FDA-approved for human use. Always consult qualified healthcare providers and conduct thorough due diligence before use.
